Trial intelligence / Profile preview

Comparison of different methods of tranexamic acid administration on postoperative blood loss in total knee arthroplasty

IRCT20160105025871N2Phase 3Completed

Sponsor
Kerman University of Medical Sciences
Start
Sep 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of tranexamic acid in postoperative hemorrhage, sponsored by Kerman University of Medical Sciences. Primary endpoint: Postoperative blood loss. Started Sep 2019; status: completed.

02

Drugs

tranexamic acid
03

Conditions

postoperative hemorrhage

Beyond the preview

Go deeper on IRCT20160105025871N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20160105025871N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call